Form 8-K - Current report:
SEC Accession No. 0001558370-24-008619
Filing Date
2024-05-24
Accepted
2024-05-24 08:00:18
Documents
13
Period of Report
2024-05-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20240522x8k.htm   iXBRL 8-K 36139
  Complete submission text file 0001558370-24-008619.txt   152642

Data Files

Seq Description Document Type Size
2 EX-101.SCH bpmc-20240522.xsd EX-101.SCH 3162
3 EX-101.LAB bpmc-20240522_lab.xml EX-101.LAB 15240
4 EX-101.PRE bpmc-20240522_pre.xml EX-101.PRE 9839
16 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20240522x8k_htm.xml XML 4673
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 24980857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)